Track topics on Twitter Track topics that are important to you
2411 Stanwell Drive
United States of America
Phone: (925) 288-6000
Fax: (925) 288-6001
Cerus Corporation (Nasdaq:CERS) announced today that William ‘Obi’ Greenman, Cerus’ president and chief executive officer, and Kevin Green, Cerus’ vice president, finance ...
Cerus Corporation (Nasdaq: CERS) today announced that William ‘Obi’ Greenman, Cerus’ president and chief executive officer, will present and provide a corporate update at th...
Cerus Corporation (Nasdaq: CERS) today announced that Kevin D. Green, Cerus’ vice president, finance and chief financial officer, will present and provide a corporate update at ...
FREMONT, Calif. and OXFORD, England, Nov. 27, 2018 /PRNewswire/ -- Cerus Endovascular Ltd., a privately held medical device company engaged in the design and development Read more...
Cerus Corporation (Nasdaq:CERS) announced today that William ‘Obi’ Greenman, Cerus’ president and chief executive officer, and Vivek Jayaraman, Cerus’ chief commercial off...
The basis of the designation is improved treatment of massive hemorrhage, a life-threatening medical condition. Cerus chief scientific officer Laurence Corash said: “The proposed label indication fo...
The CERUS (Contour Neurovascular System European Pre-Market Unruptured Aneurysm Study) study is designed to assess the safety of the company’s Contour neurovascular system, which is designed to ...
Cerus Corporation (Nasdaq: CERS) today announced that it will host an Institutional Investor Meeting on Tuesday, October 16, 2018 in Boston, Massachusetts. The pro...
A series of 2-Cl-benzimidazole derivatives was synthesized and assessed for antibacterial activity. Antibacterial results indicated that compounds 2d, 2e, 3a, 3b, 3c, 4d and 4e showed promising activi...
A new series of heterocyclic molecules bearing sulfonamide linkage has been synthesized and screened for antibacterial activity. During antibacterial screening using broath dilution method, molecules ...
A series of molecules bearing oxathiadiazole, a five membered heterocyclic ring has been designed, synthesized and screened for antimicrobial activity. Molecules, 1a, 1b, 1d, 3a-b and 4a-b were found ...
Cerus Endovascular is sponsoring a prospective, multi-center trial to document the safety and performance of the Contour Neurovascular System™ ("Contour"). The purpose of the study is t...
At Cerus Corporation we have developed a platform technology (Helinx®) that prevents nucleic acid (DNA and RNA) replication. The Company's initial application of this technology is the development o...
Condensed Consolidated Unaudited Balance Sheets
We have published hundreds of Cerus news stories on BioPortfolio along with dozens of Cerus Clinical Trials and PubMed Articles about Cerus for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cerus Companies in our database. You can also find out about relevant Cerus Drugs and Medications on this site too.
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells. In vertebrates, it is composed of blo...